The CentraCare Heart & Vascular Center at St. Cloud Hospital is seeking patients to participate in a clinic research study. Male or female participants who are 50 years of age or older may be eligible to participate if they have had a myocardial infarction (MI) one to three years ago and have at least one of the following risk factors:
•Age 65 or older;
•Diabetes mellitus requiring medication;
•Documented history of a second prior MI;
•Multi-vessel coronary artery disease;
•Chronic non-end stage renal dysfunction.
This study is being carried out to see if an investigational drug, given twice daily in addition to aspirin therapy, decreases the frequency of cardiovascular events (e.g., death from heart disease, heart attack or stroke). An investigational drug is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA).
Approximately 21,000 patients will take part in this study globally. Patients will participate in the study for approximately 38 months. Study visits will take place every four months for the first year and then every six months thereafter. The investigational drug during the study will be provided at no charge. Participants will be reimbursed for their travel expenses.
For additional eligibility requirements and information about this study, please contact Research Coordinator Peggy Dahl, R.N., CentraCare Heart & Vascular Center, at (320) 251-2700, ext. 52187, or e-mail [email protected]